Simplex Trading’s Nuvation Bio NUVB Stock Holding History

Simplex Trading’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$147K	Buy	+34,338	New	+$191K	﹤0.01%	4652
2025 Q4	–	Sell	-115,559	Closed	-$716K	–	9600
2025 Q3	$427K	Buy	115,559 +77,905	+207%	+$212K	﹤0.01%	4026
2025 Q2	$73K	Buy	37,654 +26,707	+244%	+$55.6K	﹤0.01%	5539
2025 Q1	$19K	Sell	10,947 -41,790	-79%	-$95.1K	﹤0.01%	6618
2024 Q4	$140K	Buy	52,737 +5,040	+11%	+$13K	﹤0.01%	4865
2024 Q3	$109K	Buy	47,697 +40,641	+576%	+$124K	﹤0.01%	5135
2024 Q2	$20K	Buy	+7,056	New	+$21.5K	﹤0.01%	6897
2023 Q3	–	Sell	-18	Closed	-$30	–	9469
2023 Q2	$0	Buy	+18	New	+$31	﹤0.01%	9616
2022 Q3	–	Sell	-300	Closed	–	–	10585
2022 Q2	$0	Buy	+300	New	+$1.31K	﹤0.01%	10723
2021 Q4	–	Sell	-1,827	Closed	-$16.8K	–	11116
2021 Q3	$17K	Hold	1,827	–	–	﹤0.01%	8569
2021 Q2	$17K	Buy	+1,827	New	+$20.8K	﹤0.01%	8720

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Simplex Trading's NUVB Position: Q1 2026 in Review

Simplex Trading opened a new position in Nuvation Bio (NUVB) in Q1 2026: 34,338 shares worth $147K. The stake represents ﹤0.01% of the portfolio and ranks #4652 among its holdings. This is a return to the name: Simplex Trading previously reported a position in NUVB as recently as Q3 2025.

Simplex Trading first reported a position in NUVB in Q2 2021 and has held it in 11 quarters since. The position peaked at $427K in Q3 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

Simplex Trading held 34,338 shares of Nuvation Bio worth $147K as of Q1 2026.
Nuvation Bio was a new Simplex Trading position in Q1 2026.
Nuvation Bio made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4652 holding.
Simplex Trading first reported a position in Nuvation Bio in Q2 2021 and has held it in 11 quarters since.
Simplex Trading's Nuvation Bio position peaked at $427K in Q3 2025.
231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.